CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Kwong Ming Fock, Ngai Moh Law, Sin-Yoong Chong, Fria Gloriba Manejero, Tiing-Leong Ang, Eng Kiong Teo, Jessica Tan
Clin Mol Hepatol. 2021;27(3):474-485.   Published online 2021 February 19    DOI:

Excel Download

The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Clinical and Molecular Hepatology. 2021;27(3):474-485   Crossref logo
Link1 Link2 Link3

2228. Late Viral Relapse After Direct-Acting Antiviral Treatment in Hepatitis C Virus-Infected Cancer Patients
Open Forum Infectious Diseases. 2018;5(suppl_1):S659-S659   Crossref logo

Changes in Kidney Function in Patients Co-Infected with Human Immunodeficiency Virus and Hepatitis C Virus Being Treated with Direct-Acting Antiviral and Antiretrovirals
American Journal of Kidney Diseases. 2017;69(4):A73   Crossref logo
Link1 Link2

Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and insurance Status
American Journal of Gastroenterology. 2018;113(9):1285-1286   Crossref logo
Link1 Link2 Link3 Link4

Hepatitis B virus reactivation during direct-acting antiviral therapy in hepatitis B/C co-infected patients on hemodialysis
Journal of Hepatology. 2018;68:S294   Crossref logo
Link1 Link2

NS3 inhibition coupled with potent direct acting antiviral combinations leads to enhanced hepatitis C virus specific immunity in hepatitis C virus-human immunodeficiency virus co-infected patients
Journal of Hepatology. 2017;66(1):S329   Crossref logo
Link1 Link2

Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China
Infection and Drug Resistance. 2017;Volume 10:377-392   Crossref logo
Link1 Link2

Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors’ reply
Alimentary Pharmacology & Therapeutics. 2017;45(5):758-759   Crossref logo
Link1 Link2

Resistance to Direct-Acting Antiviral Agents in Treatment of Hepatitis C Virus Infections
Update on Hepatitis C. 2017;   Crossref logo

Hepatitis C genotype 1 infection in HIV-Infected patients in the era of direct-acting antiviral therapy
Clinical Liver Disease. 2012;1(3):69-72   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.